HEADER TRANSFERASE 12-MAR-18 6FYR TITLE X-RAY STRUCTURE OF CLK3-KD(GP-[275-632], NON-PHOS.)/CPD-2 AT 1.42A COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE CLK3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: CDC-LIKE KINASE 3; COMPND 6 EC: 2.7.12.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLK3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS SPLICING, TRANSFERASE, KINASE, TYROSINE-PROTEIN KINASE, SERINE/ KEYWDS 2 THREONINE- PROTEIN KINASE, NUCLEOTIDE-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR J.KALLEN REVDAT 5 17-JAN-24 6FYR 1 REMARK REVDAT 4 03-OCT-18 6FYR 1 REMARK REVDAT 3 26-SEP-18 6FYR 1 JRNL REVDAT 2 12-SEP-18 6FYR 1 JRNL REVDAT 1 18-JUL-18 6FYR 0 JRNL AUTH J.KALLEN,C.BERGSDORF,B.ARNAUD,M.BERNHARD,M.BRICHET, JRNL AUTH 2 A.COBOS-CORREA,A.ELHAJOUJI,F.FREULER,I.GALIMBERTI, JRNL AUTH 3 C.GUIBOURDENCHE,S.HAENNI,S.HOLZINGER,J.HUNZIKER,A.IZAAC, JRNL AUTH 4 M.KAUFMANN,L.LEDER,H.J.MARTUS,P.VON MATT,V.POLYAKOV, JRNL AUTH 5 P.ROETHLISBERGER,G.ROMA,N.STIEFL,M.UTENG,A.LERCHNER JRNL TITL X-RAY STRUCTURES AND FEASIBILITY ASSESSMENT OF CLK2 JRNL TITL 2 INHIBITORS FOR PHELAN-MCDERMID SYNDROME. JRNL REF CHEMMEDCHEM V. 13 1997 2018 JRNL REFN ESSN 1860-7187 JRNL PMID 29985556 JRNL DOI 10.1002/CMDC.201800344 REMARK 2 REMARK 2 RESOLUTION. 1.42 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.42 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 64846 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3413 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2935 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 529 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.07000 REMARK 3 B22 (A**2) : -0.16000 REMARK 3 B33 (A**2) : 0.22000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.16000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.085 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.065 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.036 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.993 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6FYR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1200009144. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00003 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68259 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.420 REMARK 200 RESOLUTION RANGE LOW (A) : 19.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.42 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.46 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.45300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6FYP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG4000, 0.1M HEPES, PH 7.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 54.46600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.46450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 54.46600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.46450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 125 REMARK 465 PRO A 126 REMARK 465 GLN A 127 REMARK 465 HIS A 483 REMARK 465 THR A 484 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 606 O HOH A 1081 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 155 -47.88 -146.09 REMARK 500 THR A 282 -13.15 79.38 REMARK 500 ASP A 320 76.24 58.36 REMARK 500 ALA A 336 158.51 72.55 REMARK 500 ALA A 352 -149.00 -154.13 REMARK 500 GLU A 478 -45.63 -177.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1124 DISTANCE = 5.88 ANGSTROMS REMARK 525 HOH A1125 DISTANCE = 5.89 ANGSTROMS REMARK 525 HOH A1126 DISTANCE = 5.99 ANGSTROMS REMARK 525 HOH A1127 DISTANCE = 6.18 ANGSTROMS REMARK 525 HOH A1128 DISTANCE = 6.38 ANGSTROMS REMARK 525 HOH A1129 DISTANCE = 7.05 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EAQ A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6FYI RELATED DB: PDB REMARK 900 RELATED ID: 6FYK RELATED DB: PDB REMARK 900 RELATED ID: 6FYL RELATED DB: PDB REMARK 900 RELATED ID: 6FYO RELATED DB: PDB REMARK 900 RELATED ID: 6FYP RELATED DB: PDB DBREF 6FYR A 127 484 UNP P49761 CLK3_HUMAN 275 632 SEQADV 6FYR GLY A 125 UNP P49761 EXPRESSION TAG SEQADV 6FYR PRO A 126 UNP P49761 EXPRESSION TAG SEQRES 1 A 360 GLY PRO GLN SER SER LYS ARG SER SER ARG SER VAL GLU SEQRES 2 A 360 ASP ASP LYS GLU GLY HIS LEU VAL CYS ARG ILE GLY ASP SEQRES 3 A 360 TRP LEU GLN GLU ARG TYR GLU ILE VAL GLY ASN LEU GLY SEQRES 4 A 360 GLU GLY THR PHE GLY LYS VAL VAL GLU CYS LEU ASP HIS SEQRES 5 A 360 ALA ARG GLY LYS SER GLN VAL ALA LEU LYS ILE ILE ARG SEQRES 6 A 360 ASN VAL GLY LYS TYR ARG GLU ALA ALA ARG LEU GLU ILE SEQRES 7 A 360 ASN VAL LEU LYS LYS ILE LYS GLU LYS ASP LYS GLU ASN SEQRES 8 A 360 LYS PHE LEU CYS VAL LEU MET SER ASP TRP PHE ASN PHE SEQRES 9 A 360 HIS GLY HIS MET CYS ILE ALA PHE GLU LEU LEU GLY LYS SEQRES 10 A 360 ASN THR PHE GLU PHE LEU LYS GLU ASN ASN PHE GLN PRO SEQRES 11 A 360 TYR PRO LEU PRO HIS VAL ARG HIS MET ALA TYR GLN LEU SEQRES 12 A 360 CYS HIS ALA LEU ARG PHE LEU HIS GLU ASN GLN LEU THR SEQRES 13 A 360 HIS THR ASP LEU LYS PRO GLU ASN ILE LEU PHE VAL ASN SEQRES 14 A 360 SER GLU PHE GLU THR LEU TYR ASN GLU HIS LYS SER CYS SEQRES 15 A 360 GLU GLU LYS SER VAL LYS ASN THR SER ILE ARG VAL ALA SEQRES 16 A 360 ASP PHE GLY SER ALA THR PHE ASP HIS GLU HIS HIS THR SEQRES 17 A 360 THR ILE VAL ALA THR ARG HIS TYR ARG PRO PRO GLU VAL SEQRES 18 A 360 ILE LEU GLU LEU GLY TRP ALA GLN PRO CYS ASP VAL TRP SEQRES 19 A 360 SER ILE GLY CYS ILE LEU PHE GLU TYR TYR ARG GLY PHE SEQRES 20 A 360 THR LEU PHE GLN THR HIS GLU ASN ARG GLU HIS LEU VAL SEQRES 21 A 360 MET MET GLU LYS ILE LEU GLY PRO ILE PRO SER HIS MET SEQRES 22 A 360 ILE HIS ARG THR ARG LYS GLN LYS TYR PHE TYR LYS GLY SEQRES 23 A 360 GLY LEU VAL TRP ASP GLU ASN SER SER ASP GLY ARG TYR SEQRES 24 A 360 VAL LYS GLU ASN CYS LYS PRO LEU LYS SER TYR MET LEU SEQRES 25 A 360 GLN ASP SER LEU GLU HIS VAL GLN LEU PHE ASP LEU MET SEQRES 26 A 360 ARG ARG MET LEU GLU PHE ASP PRO ALA GLN ARG ILE THR SEQRES 27 A 360 LEU ALA GLU ALA LEU LEU HIS PRO PHE PHE ALA GLY LEU SEQRES 28 A 360 THR PRO GLU GLU ARG SER PHE HIS THR HET EAQ A 501 27 HETNAM EAQ 6-~{TERT}-BUTYL-~{N}-[6-(1~{H}-PYRAZOL-4-YL)-1~{H}- HETNAM 2 EAQ IMIDAZO[1,2-A]PYRIDIN-2-YL]PYRIDINE-3-CARBOXAMIDE FORMUL 2 EAQ C20 H21 N6 O FORMUL 3 HOH *529(H2 O) HELIX 1 AA1 SER A 128 SER A 135 1 8 HELIX 2 AA2 ALA A 177 GLY A 179 5 3 HELIX 3 AA3 VAL A 191 ASP A 212 1 22 HELIX 4 AA4 ASN A 242 ASN A 250 1 9 HELIX 5 AA5 PRO A 256 ASN A 277 1 22 HELIX 6 AA6 LYS A 285 GLU A 287 5 3 HELIX 7 AA7 THR A 337 ARG A 341 5 5 HELIX 8 AA8 PRO A 342 LEU A 347 1 6 HELIX 9 AA9 GLN A 353 GLY A 370 1 18 HELIX 10 AB1 GLU A 378 GLY A 391 1 14 HELIX 11 AB2 PRO A 394 THR A 401 1 8 HELIX 12 AB3 LYS A 403 LYS A 405 5 3 HELIX 13 AB4 SER A 418 CYS A 428 1 11 HELIX 14 AB5 PRO A 430 MET A 435 5 6 HELIX 15 AB6 SER A 439 LEU A 453 1 15 HELIX 16 AB7 THR A 462 LEU A 467 1 6 HELIX 17 AB8 LEU A 468 LEU A 475 5 8 SHEET 1 AA1 6 TRP A 151 LEU A 152 0 SHEET 2 AA1 6 TYR A 156 GLY A 165 -1 O TYR A 156 N LEU A 152 SHEET 3 AA1 6 GLY A 168 ASP A 175 -1 O GLU A 172 N VAL A 159 SHEET 4 AA1 6 GLN A 182 ILE A 188 -1 O LEU A 185 N VAL A 171 SHEET 5 AA1 6 HIS A 231 GLU A 237 -1 O MET A 232 N ILE A 188 SHEET 6 AA1 6 MET A 222 PHE A 228 -1 N PHE A 228 O HIS A 231 SHEET 1 AA2 2 LEU A 279 THR A 280 0 SHEET 2 AA2 2 THR A 325 PHE A 326 -1 O THR A 325 N THR A 280 SHEET 1 AA3 2 ILE A 289 PHE A 291 0 SHEET 2 AA3 2 ILE A 316 VAL A 318 -1 O ARG A 317 N LEU A 290 SHEET 1 AA4 2 PHE A 296 TYR A 300 0 SHEET 2 AA4 2 GLU A 308 VAL A 311 -1 O GLU A 308 N LEU A 299 SHEET 1 AA5 2 PHE A 407 TYR A 408 0 SHEET 2 AA5 2 GLY A 411 LEU A 412 -1 O GLY A 411 N TYR A 408 SITE 1 AC1 11 ALA A 184 PHE A 236 GLU A 237 LEU A 238 SITE 2 AC1 11 LEU A 239 LEU A 290 ASP A 320 HOH A 644 SITE 3 AC1 11 HOH A 648 HOH A 720 HOH A 785 CRYST1 108.932 44.929 83.635 90.00 114.82 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009180 0.000000 0.004245 0.00000 SCALE2 0.000000 0.022257 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013173 0.00000